Tropism Switching Is Rare in Aviremic HIV-Infected Patients Virologically Suppressed With Non-Entry-Inhibiting Antiretroviral Regimens [0.03%]
非进入抑制型抗逆转录病毒方案病毒学抑制的无病毒血症HIV感染患者中的生长素转换罕见
Louis M Sloan,Mezgebe G Berhe,Anna Ursales et al.
Louis M Sloan et al.
Anti-Factor Xa Activity of Fixed-Dose Fondaparinux in Low-Body-Weight Patients With Acute Coronary Syndrome [0.03%]
低体重急性冠脉综合征患者固定剂量 fondaparinux 的抗 FXa 活性
Wanwarang Wongcharoen,Nualnit Tantisirivit,Lalita Norasetthada et al.
Wanwarang Wongcharoen et al.
Background: Fixed-dose 2.5 mg of fondaparinux subcutaneous injection once daily has been recommended in treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS) irrespective of body weight (BW). However, d...
Emerging Pharmacotherapy and Health Care Needs of Patients in the Age of Artificial Intelligence and Digitalization [0.03%]
人工智能与数字化时代背景下患者的新兴药物治疗及医疗需求
Barbara J Zarowitz
Barbara J Zarowitz
Advances in the application of artificial intelligence, digitization, technology, iCloud computing, and wearable devices in health care predict an exciting future for health care professionals and our patients. Projections suggest an older,...
CORRIGENDUM to Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19) [0.03%]
关于“克力芝用于治疗新型冠状病毒肺炎”应急审批的更正公告（更新为“羟氯喹用于治疗新型冠状病毒肺炎”紧急使用授权）
Published Erratum
The Annals of pharmacotherapy. 2020 Aug;54(8):832. DOI:10.1177/1060028020932400 2020
Direct Oral Anticoagulants in Obesity: An Updated Literature Review [0.03%]
肥胖患者使用直接口服抗凝药的疗效和安全性：最新文献回顾
Jamielynn Sebaaly,Denise Kelley
Jamielynn Sebaaly
Objective: To review literature on the use of direct-acting oral anticoagulants (DOACs) in patients with high body weight (BW) and/or high body mass index (BMI) and to make recommendations regarding use in this patient po...
The Use of Gentamicin for Treatment of Urogenital and Extragenital Gonorrhea: A Systematic Review of Efficacy Data [0.03%]
用于治疗泌尿生殖道和非泌尿生殖道淋病的庆大霉素的疗效系统的文献回顾
Paul Burmeister,Simon Su,Alesha J Smith et al.
Paul Burmeister et al.
Objective: To evaluate clinical efficacy data for gentamicin in the treatment of gonorrhea. Data sources: A keyword search of PubMed (1...
The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease [0.03%]
抑制炎症在动脉粥样硬化性心血管疾病治疗中的作用
Yuani M Roman,Adrian V Hernandez,C Michael White
Yuani M Roman
Objective: To review the 3 anti-inflammatory drugs, canakinumab, colchicine, and methotrexate, that have been investigated in major clinical trials for treating patients with atherosclerotic cardiovascular disease (ASCVD)...
Is Warfarin-Induced Rapid Rise in INR Post-Cardiac Surgery Associated With Increased Bleeding Risk? [0.03%]
华法林使心脏手术后的INR快速升高是否增加出血风险？
Niloofar Khoshnam-Rad,Mona Kargar
Niloofar Khoshnam-Rad
Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate [0.03%]
固定剂量的四因子凝血酶原复合物浓缩剂治疗华法林逆转的研究
Brianna Jansma,Josephine Montgomery,Scott Dietrich et al.
Brianna Jansma et al.
Background: Four-factor prothrombin complex concentrate (4FPCC) is used for emergent warfarin reversal, but dosing remains controversial. Following approval, further studies have evaluated a variety of fixed-dose regimens...
Chaker Ben Salem,Dhouha Sahnoun,Raoudha Slim et al.
Chaker Ben Salem et al.